請輸入關鍵字:

熱門搜尋:

PMI Explores Global Public Health Issues in New White Paper

日期:2019年1月23日 下午3:38

Explores the Role of Governments, Corporate Ingenuity and Consumers’ Self-Interests

LAUSANNE, Switzerland--()--In a new White Paper, “Public Health—Much Harder than Rocket Science,” Philip Morris International (PMI) (NYSE:PM) looks at the dynamics between consumers, corporations and authorities across a range of global public health issues. It is based on a recent global survey conducted by IPSOS.

Consumers all over the world want their governments to do better at solving major public health issues, according to the IPSOS survey of 31,000 respondents across 31 countries commissioned by PMI. In the survey, respondents were asked how important they believed it is for governments to dedicate time and resources to nine global health issues: air pollution, mental health, STDs, healthier food products, opioid abuse, smoking and alcohol abuse, unwanted pregnancies and obesity.

When asked about the role of technology and innovation in addressing these issues, 91 per cent of respondents believed technology and innovation had an important role to play. However, respondents did not evaluate government performance highly; more than half (56 per cent) believed the authorities had done a poor job of ensuring access to the latest innovations and advancements that can improve public health.

Introduced by PMI in Davos, “Public Health—Much Harder than Rocket Science,” reviews further the discussions surrounding these important public health issues and the interplays between public vs. private impact and human behavior. It concludes that a collaborative approach is possible: Corporations themselves may well be able to help address some of the public health issues relating to their products. And, authorities would be well advised to tap into corporate resources and use their ingenuity and self-interest to create compelling solutions. With the right discussion and oversight, corporations can be reliable partners in helping governments deal with some of today’s public health issues.

“Given the scale of these public health challenges, it’s unrealistic to expect advice and exhortations from health authorities alone to make the difference,” argues Marian Salzman, Senior Vice President, Global Communications at PMI. “To truly help large numbers of people make the changes they want and need will take a combination of evidence-based public policy initiatives, new technologies and new products. The public deserve—and are asking—to hear about better possibilities, regardless of where they have come from.”

For more information or to read the complete White Paper, or to learn more about what PMI is doing to create a smoke-free future visit, PMI.com.

# # #

Survey Methodology

Conducted by IPSOS Hong Kong Limited (September 2018); margin of error ±0.6% at the 95 percent confidence interval. All data can be viewed at https://www.pmi.com/media-center/news/public-supports-alternatives-to-cigarettes.

Philip Morris International: Building a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories, and other nicotine containing products in markets outside the U.S. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free IQOS product portfolio includes heated tobacco and nicotine-containing vapor products. As of September 30, 2018, PMI estimates that approximately 5.9 million adult smokers around the world have already stopped smoking and switched to PMI’s heated tobacco product, which is currently available for sale in 43 markets in key cities or nationwide under the IQOS brand. For more information, see our PMI and PMIScience websites.

 

Contacts

Ryan Sparrow
Philip Morris International
T: +41 79 549 1968
E: Ryan.Sparrow@pmi.com

財華網所刊載內容之知識產權為財華網及相關權利人專屬所有或持有。未經許可,禁止進行轉載、摘編、複製及建立鏡像等任何使用。

如有意願轉載,請發郵件至content@finet.com.hk,獲得書面確認及授權後,方可轉載。

下載財華財經APP,把握投資先機
https://www.finet.com.cn/app

更多精彩内容,請點擊:
財華網(https://www.finet.hk/)
財華智庫網(https://www.finet.com.cn)
現代電視FINTV(https://www.fintv.hk)

相關文章

1月23日
BIOCERES和UNION ACQUISITION CORP.公佈Bioceres截至2018年12月31日期間未經審計的季度經營業績
1月22日
GA Telesis董事會任命Norman Liu為獨立董事
1月22日
MWC19巴塞隆納即將來臨,業界對此高度期待
1月22日
CNIM將為法國海軍建造14艘新的標準兩棲登陸艇(EDA-S)
1月22日
Metabolon任命Michael Rasche為國際業務總裁
1月22日
瑞思邁首款頭戴式CPAP面罩AirFit N30i現已在全美上市
1月22日
科衆集團聚力呈現2019創新服務峰會——「碰撞·革新」
1月22日
HCL 2030生態系統平臺將在世界經濟論壇探討新興科技的社會意涵
1月22日
現代摩比斯去年核心配件拿到史上最多海外訂單,超過「1.9萬億韓元」(17億美元)
1月22日
MagicStay推出全新忠誠度計畫

視頻

快訊

09:45
【異動股】貴金屬板塊拉升,湖南白銀(002716.CN)漲4.32%
09:45
【異動股】F5G概念板塊拉升,長芯博創(300548.CN)漲12.31%
09:45
【異動股】港股跌幅榜前十,明基醫院(02581.HK)跌30.94%,南華期貨股份(02691.HK)跌22.42%
09:45
【異動股】港股漲幅榜前十,中原建業(09982.HK)漲60.00%,首都創投(02324.HK)漲37.10%
09:41
來凱醫藥-B(02105.HK)LAE102治療肥胖症的I期多劑量擴展研究完成首例受試者給藥
09:31
【異動股】教育板塊低開,中國高科(600730.CN)跌9.99%
09:31
【異動股】SPD概念板塊低開,華人健康(301408.CN)跌7.41%
09:31
【異動股】能源金屬板塊高開,天華新能(300390.CN)漲5.98%
09:31
【異動股】民爆概念板塊高開,國泰集團(603977.CN)漲9.99%
08:45
中原建業(09982.HK)復牌